US Officials Hope To Identify Correlates of Protection For COVID-19 Vaccines Shortly

 
• By Sarah Karlin-Smith

Accelerated approval might soon be in the cards for COVID-19 vaccines if an immune correlate of protection can be identified through ongoing work by FDA and NIH. Meanwhile, to speed more vaccines to Americans, FDA is trying to help ramp up manufacturing. Sanofi is set to commence a Phase IIb trial with an active comparator. 

Coronavirus_Vaccine
The next generation of COVID-19 vaccines could be deveopled with simpler clinical trials. • Source: Shutterstock

More from Vaccines

More from Pink Sheet